skip to content
Empagliflozin (Jardiance). Preview this item
ClosePreview this item
Checking...

Empagliflozin (Jardiance).

Author: Canadian Agency for Drugs and Technologies in Health,
Publisher: Ottawa (ON) : Canadian Agency for Drugs and Technologies in Health, October 2015.
Series: Common drug review clinical review report.
Edition/Format:   eBook : Document : English
Summary:
The objective of this review was to perform a systematic review of the beneficial and harmful effects of empagliflozin for the treatment of adults with type 2 diabetes who have experienced inadequate glycemic control on combination therapy with metformin and a sulfonylurea.
Rating:

(not yet rated) 0 with reviews - Be the first.

Subjects
More like this

Find a copy online

Links to this item

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...

Details

Genre/Form: Review
Table
Material Type: Document, Internet resource
Document Type: Internet Resource, Computer File
All Authors / Contributors: Canadian Agency for Drugs and Technologies in Health,
OCLC Number: 1088823713
Notes: "Manufacturer, Boehringer Ingelheim."
Description: 1 online resource (1 PDF file (ix, 58 pages)) : illustrations.
Series Title: Common drug review clinical review report.
Other Titles: CDR clinical review report for Jardiance

Abstract:

The objective of this review was to perform a systematic review of the beneficial and harmful effects of empagliflozin for the treatment of adults with type 2 diabetes who have experienced inadequate glycemic control on combination therapy with metformin and a sulfonylurea.

Reviews

User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...

Tags

Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Linked Data


Primary Entity

<http://www.worldcat.org/oclc/1088823713> # Empagliflozin (Jardiance).
    a schema:CreativeWork, schema:MediaObject, schema:Book ;
    library:oclcnum "1088823713" ;
    library:placeOfPublication <http://id.loc.gov/vocabulary/countries/onc> ;
    schema:about <http://experiment.worldcat.org/entity/work/data/8951442038#Place/canada> ; # Canada.
    schema:about <http://experiment.worldcat.org/entity/work/data/8951442038#Topic/hypoglycemic_agents_therapeutic_use> ; # Hypoglycemic Agents--therapeutic use
    schema:about <http://experiment.worldcat.org/entity/work/data/8951442038#Topic/diabetes_mellitus_type_2_drug_therapy> ; # Diabetes Mellitus, Type 2--drug therapy
    schema:about <http://experiment.worldcat.org/entity/work/data/8951442038#Topic/sodium_glucose_transporter_2_inhibitors_therapeutic_use> ; # Sodium-Glucose Transporter 2 Inhibitors--therapeutic use
    schema:about <http://experiment.worldcat.org/entity/work/data/8951442038#Topic/drug_therapy_combination> ; # Drug Therapy, Combination
    schema:alternateName "CDR clinical review report for Jardiance" ;
    schema:bookFormat schema:EBook ;
    schema:contributor <http://experiment.worldcat.org/entity/work/data/8951442038#Organization/canadian_agency_for_drugs_and_technologies_in_health> ; # Canadian Agency for Drugs and Technologies in Health,
    schema:datePublished "2015" ;
    schema:description "The objective of this review was to perform a systematic review of the beneficial and harmful effects of empagliflozin for the treatment of adults with type 2 diabetes who have experienced inadequate glycemic control on combination therapy with metformin and a sulfonylurea."@en ;
    schema:exampleOfWork <http://worldcat.org/entity/work/id/8951442038> ;
    schema:genre "Review"@en ;
    schema:genre "Table"@en ;
    schema:inLanguage "en" ;
    schema:isPartOf <http://experiment.worldcat.org/entity/work/data/8951442038#Series/common_drug_review_clinical_review_report> ; # Common drug review clinical review report.
    schema:isPartOf <http://experiment.worldcat.org/entity/work/data/8951442038#Series/cadth_common_drug_review_clinical_review_report> ; # CADTH common drug review clinical review report
    schema:name "Empagliflozin (Jardiance)."@en ;
    schema:productID "1088823713" ;
    schema:url <http://www.ncbi.nlm.nih.gov/books/NBK534172/> ;
    wdrs:describedby <http://www.worldcat.org/title/-/oclc/1088823713> ;
    .


Related Entities

<http://experiment.worldcat.org/entity/work/data/8951442038#Organization/canadian_agency_for_drugs_and_technologies_in_health> # Canadian Agency for Drugs and Technologies in Health,
    a schema:Organization ;
    schema:name "Canadian Agency for Drugs and Technologies in Health," ;
    .

<http://experiment.worldcat.org/entity/work/data/8951442038#Series/cadth_common_drug_review_clinical_review_report> # CADTH common drug review clinical review report
    a bgn:PublicationSeries ;
    schema:hasPart <http://www.worldcat.org/oclc/1088823713> ; # Empagliflozin (Jardiance).
    schema:name "CADTH common drug review clinical review report" ;
    .

<http://experiment.worldcat.org/entity/work/data/8951442038#Series/common_drug_review_clinical_review_report> # Common drug review clinical review report.
    a bgn:PublicationSeries ;
    schema:hasPart <http://www.worldcat.org/oclc/1088823713> ; # Empagliflozin (Jardiance).
    schema:name "Common drug review clinical review report." ;
    .

<http://experiment.worldcat.org/entity/work/data/8951442038#Topic/diabetes_mellitus_type_2_drug_therapy> # Diabetes Mellitus, Type 2--drug therapy
    a schema:Intangible ;
    schema:name "Diabetes Mellitus, Type 2--drug therapy"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/8951442038#Topic/drug_therapy_combination> # Drug Therapy, Combination
    a schema:Intangible ;
    schema:name "Drug Therapy, Combination"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/8951442038#Topic/hypoglycemic_agents_therapeutic_use> # Hypoglycemic Agents--therapeutic use
    a schema:Intangible ;
    schema:name "Hypoglycemic Agents--therapeutic use"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/8951442038#Topic/sodium_glucose_transporter_2_inhibitors_therapeutic_use> # Sodium-Glucose Transporter 2 Inhibitors--therapeutic use
    a schema:Intangible ;
    schema:name "Sodium-Glucose Transporter 2 Inhibitors--therapeutic use"@en ;
    .


Content-negotiable representations

Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.